|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,380,000 |
Market
Cap: |
200.70(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$11.6 - $15.03 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 16.2 |
Insider 3/6 Months : 16.8 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
278,500 |
504,050 |
1,194,261 |
Total Buy Value |
$0 |
$3,532,303 |
$6,240,948 |
$13,669,512 |
Total People Bought |
0 |
1 |
2 |
4 |
Total Buy Transactions |
0 |
9 |
13 |
46 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lawler Joseph F. |
See Explanation of Responses |
|
2019-07-02 |
4 |
B |
$5.85 |
$100,182 |
I/I |
17,131 |
739,676 |
1.5 |
- |
|
Lawler Joseph F. |
See Explanation of Responses |
|
2019-07-01 |
4 |
B |
$6.00 |
$57,586 |
I/I |
9,593 |
729,569 |
1.5 |
- |
|
Lawler Joseph F. |
See Explanation of Responses |
|
2019-06-28 |
4 |
B |
$5.95 |
$140,088 |
I/I |
23,564 |
723,910 |
1.5 |
- |
|
English Aron R. |
See Explanation of Responses |
|
2019-04-17 |
4 |
B |
$6.00 |
$97,156 |
I/I |
16,200 |
1,241,896 |
1.5 |
- |
|
English Aron R. |
See Explanation of Responses |
|
2019-04-16 |
4 |
B |
$5.95 |
$121,637 |
I/I |
20,450 |
1,225,696 |
1.5 |
- |
|
English Aron R. |
See Explanation of Responses |
|
2019-04-15 |
4 |
B |
$5.73 |
$172,530 |
I/I |
30,110 |
1,205,246 |
1.5 |
- |
|
English Aron R. |
See Explanation of Responses |
|
2019-04-08 |
4 |
B |
$5.81 |
$191,035 |
I/I |
32,873 |
1,175,136 |
1.5 |
- |
|
Lawler Joseph F. |
See Explanation of Responses |
|
2019-04-08 |
4 |
B |
$5.73 |
$62,933 |
I/I |
10,990 |
489,532 |
1.5 |
- |
|
English Aron R. |
See Explanation of Responses |
|
2019-04-05 |
4 |
B |
$6.12 |
$305,760 |
I/I |
50,000 |
1,142,263 |
1.5 |
- |
|
Lawler Joseph F. |
See Explanation of Responses |
|
2019-04-05 |
4 |
B |
$5.95 |
$156,466 |
I/I |
26,288 |
703,524 |
1.5 |
- |
|
English Aron R. |
10% Owner |
|
2019-03-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,092,263 |
|
- |
|
Lin Kenneth |
10% Owner |
|
2019-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
Lawler Joseph F. |
10% Owner |
|
2019-03-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,162,262 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-15 |
4 |
S |
$14.23 |
$110,937 |
D/D |
(7,796) |
22,681 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-15 |
4 |
OE |
$13.20 |
$102,907 |
D/D |
7,796 |
30,477 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-14 |
4 |
S |
$14.20 |
$1,420 |
D/D |
(100) |
22,681 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-14 |
4 |
OE |
$13.20 |
$1,320 |
D/D |
100 |
22,781 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-13 |
4 |
S |
$14.27 |
$97,036 |
D/D |
(6,800) |
22,681 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-13 |
4 |
OE |
$13.20 |
$89,760 |
D/D |
6,800 |
29,481 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-11 |
4 |
S |
$14.46 |
$213,372 |
D/D |
(14,756) |
22,681 |
|
- |
|
Nielsen Ulrik B. |
Director |
|
2017-09-11 |
4 |
OE |
$13.20 |
$194,779 |
D/D |
14,756 |
37,437 |
|
- |
|
Drummond Daryl C |
Head of Research |
|
2017-05-12 |
4 |
S |
$3.72 |
$15,241 |
I/I |
(4,097) |
101,731 |
|
- |
|
Drummond Daryl C |
Head of Research |
|
2017-05-12 |
4 |
OE |
$2.69 |
$11,021 |
I/I |
4,097 |
105,828 |
|
- |
|
Drummond Daryl C |
Head of ResearchOfficer |
|
2017-03-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,311 |
|
- |
|
Drummond Daryl C |
Head of ResearchOfficer |
|
2017-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
92,420 |
|
- |
|
410 Records found
|
|
Page 6 of 17 |
|
|